Ieq Capital LLC Sells 12,472 Shares of Cardinal Health, Inc. $CAH

Key Points

• Ieq Capital LLC significantly reduced its stake in Cardinal Health, decreasing its holdings by **80.6%** in the first quarter, bringing their total shares down to **3,005** valued at **$414,000**.
• CEO Stephen M. Mason and insider Ola M. Snow both made substantial stock sales, with Mason selling **41,575 shares** and Snow selling **28,151 shares**, each reflecting over a **60% decrease** in their ownership positions.
• Cardinal Health is set to pay a quarterly dividend of **$0.5107** on **October 15**, with a current annualized dividend yield of **1.4%** and a payout ratio of **31.63%**.

Ieq Capital LLC trimmed its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 80.6% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,005 shares of the company's stock after selling 12,472 shares during the period. Ieq Capital LLC's holdings in Cardinal Health were worth $414,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Aptus Capital Advisors LLC increased its stake in Cardinal Health by 97.8% in the 4th quarter. Aptus Capital Advisors LLC now owns 3,796 shares of the company's stock worth $449,000 after purchasing an additional 1,877 shares during the period. Captrust Financial Advisors increased its stake in Cardinal Health by 2.8% in the 4th quarter. Captrust Financial Advisors now owns 25,913 shares of the company's stock worth $3,065,000 after purchasing an additional 715 shares during the period. Cetera Investment Advisers increased its stake in Cardinal Health by 1.4% in the 4th quarter. Cetera Investment Advisers now owns 103,688 shares of the company's stock worth $12,263,000 after purchasing an additional 1,443 shares during the period. CoreCap Advisors LLC increased its stake in Cardinal Health by 4.4% in the 4th quarter. CoreCap Advisors LLC now owns 25,785 shares of the company's stock worth $3,050,000 after purchasing an additional 1,093 shares during the period. Finally, EP Wealth Advisors LLC increased its stake in Cardinal Health by 4.4% in the 4th quarter. EP Wealth Advisors LLC now owns 5,338 shares of the company's stock worth $631,000 after purchasing an additional 225 shares during the period. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Trading Down 1.0%

Shares of CAH stock traded down $1.47 during trading hours on Wednesday, reaching $149.47. The company's stock had a trading volume of 1,962,439 shares, compared to its average volume of 2,303,330. The stock has a market capitalization of $35.69 billion, a P/E ratio of 23.17, a P/E/G ratio of 1.28 and a beta of 0.73. Cardinal Health, Inc. has a one year low of $106.54 and a one year high of $168.44. The firm's fifty day simple moving average is $155.00 and its 200 day simple moving average is $147.31.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, topping analysts' consensus estimates of $2.03 by $0.05. The firm had revenue of $60.16 billion for the quarter, compared to analyst estimates of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business's quarterly revenue was up .5% compared to the same quarter last year. During the same period last year, the company earned $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, equities research analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be given a dividend of $0.5107 per share. The ex-dividend date is Wednesday, October 1st. This represents a $2.04 annualized dividend and a dividend yield of 1.4%. Cardinal Health's payout ratio is currently 31.63%.

Insider Activity at Cardinal Health

In related news, CEO Jason M. Hollar sold 35,901 shares of Cardinal Health stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $150.04, for a total transaction of $5,386,586.04. Following the sale, the chief executive officer directly owned 200,000 shares in the company, valued at $30,008,000. The trade was a 15.22% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Ola M. Snow sold 28,151 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.94, for a total value of $4,192,809.94. Following the sale, the insider owned 15,431 shares in the company, valued at $2,298,293.14. This represents a 64.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 271,676 shares of company stock valued at $40,489,525 over the last ninety days. Insiders own 0.09% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on CAH. Argus set a $189.00 price target on Cardinal Health in a research note on Friday, August 22nd. Jefferies Financial Group set a $150.00 price target on Cardinal Health in a research note on Tuesday, August 12th. Evercore ISI decreased their price target on Cardinal Health from $200.00 to $190.00 and set an "outperform" rating on the stock in a research note on Wednesday, August 13th. Wall Street Zen cut Cardinal Health from a "strong-buy" rating to a "buy" rating in a research note on Saturday, August 2nd. Finally, Citigroup reaffirmed a "neutral" rating and issued a $170.00 price target (up from $157.00) on shares of Cardinal Health in a research note on Friday, June 13th. Twelve analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, Cardinal Health presently has a consensus rating of "Moderate Buy" and a consensus price target of $165.93.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.